New Delhi metallo-beta-lactamase: A weapon for the newly emerging drug-resistant bacteria.
Indian J Med Sci
;
2011 Aug; 65(8) 317-320
Artigo
em Inglês
| IMSEAR
| ID: sea-145623
ABSTRACT
The world has seen the emergence of many micro-organisms in the recent past, which can curb human population with their newly built genetic make-up. The latest addition to this list of panic creating organisms is, bacteria encoding the gene for New Delhi metallo-beta-lactamase (NDM-1). NDM-1 is an enzyme that can hydrolyze and inactivate carbapenems, which are used as a last resort for the treatment of multi-resistant bacterial infections. Names of these bacteria were not found in the medical literature before December 2009, because of which it can take the credit of becoming a powerful emerging bacteria, which are difficult to treat. Besides Escherichia coli and Klebsiella pneumoniae, other bacterial strains have also expressed the gene for NDM-1, which are detected in many countries.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Assunto principal:
Beta-Lactamases
/
Carbapenêmicos
/
Resistência beta-Lactâmica
/
Farmacorresistência Bacteriana Múltipla
/
Beta-Lactamas
/
Escherichia coli
/
Índia
/
Klebsiella pneumoniae
País/Região como assunto:
Ásia
Idioma:
Inglês
Revista:
Indian J Med Sci
Ano de publicação:
2011
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS